Literature DB >> 8428953

Characterization of the human L-plastin gene promoter in normal and neoplastic cells.

C S Lin1, Z P Chen, T Park, K Ghosh, J Leavitt.   

Abstract

Plastins are a family of human actin-binding proteins (isoforms) which are abundantly expressed in all normal replicating mammalian cells. One isoform, L-plastin, is constitutively expressed at high levels in hemopoietic cell types while T-plastin is constitutively expressed in all non-hemopoietic cells of solid tissues that have replicative potential (fibroblasts, endothelial cells, epithelial cells, melanocytes, etc.). L-plastin is, however, constitutively synthesized in many types of malignant human cells of solid tissues suggesting that its expression is induced during tumorigenesis. The frequency of L-plastin induction in some cancers of the steroid-regulated female reproductive tract (breast, ovary, uterus, and placenta) appears to be especially high (79% in a limited survey). To learn the mechanism of L-plastin gene activation accompanying tumorigenesis, we have begun to characterize the promoter and regulatory elements of the L-plastin gene. Transcription initiation from this promoter was found to occur at multiple sites and as near as 10 base pairs from the 3'-side of the TATAAA box. The promoter and its flanking DNA were cloned and sequenced to identify potential regulatory elements that participate in the induction of the L-plastin gene in neoplastic cells. Examination of upstream sequences revealed the existence of two potential progesterone, one potential estrogen, and four potential Ets-1 responsive elements flanking the promoter. A 315-base pair fragment spanning the TATAAA box and a potential Sp1-binding site exhibited maximum promoter activity using CAT as a reporter while longer promoter fragments extending into upstream flanking sequences spanning the hormone receptor-response elements exhibited reduced promoter activity. An expression vector, pHLPPr-1-neo, was constructed using a 5.1-kilobase pair EcoRI-HindIII fragment of the L-plastin gene that contained the potential upstream regulatory elements, the TATAAA box, and part of the first exon. This promoter could direct the constitutive expression of the reporter beta-galactosidase at high frequency in transfected colonies of transformed cells that express L-plastin constitutively; by contrast, this promoter was virtually inactive in transfected colonies of normal fibroblasts and it exhibited a low frequency of constitutive activation in transfected colonies of in vitro SV40-transformed fibroblasts which did not exhibit L-plastin expression. The utility of this recombinant promoter in determining the mechanism(s) that leads to activation of the L-plastin gene in tumor cells is discussed. The potential significance of regulation of the L-plastin gene by reproductive hormones in cancers arising in hormone-responsive tissues is also discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8428953

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  Regulation of growth and function of the human placenta.

Authors:  S Rama; A Jagannadha Rao
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

2.  Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy.

Authors:  Yan Ning; Armin Gerger; Wu Zhang; Diana L Hanna; Dongyun Yang; Thomas Winder; Takeru Wakatsuki; Melissa J Labonte; Sebastian Stintzing; Nico Volz; Yu Sunakawa; Stefan Stremitzer; Rita El-Khoueiry; Heinz-Josef Lenz
Journal:  Mol Cancer Ther       Date:  2013-10-29       Impact factor: 6.261

3.  Identification of regulatory elements recapitulating early expression of L-plastin in the zebrafish enveloping layer and embryonic periderm.

Authors:  Emily A Baumgartner; Zachary J Compton; Spencer Evans; Jacek Topczewski; Elizabeth E LeClair
Journal:  Gene Expr Patterns       Date:  2019-03-30       Impact factor: 1.224

4.  Steroid hormone induction and expression patterns of L-plastin in normal and carcinomatous prostate tissues.

Authors:  J Zheng; N Rudra-Ganguly; G J Miller; K A Moffatt; R J Cote; P Roy-Burman
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

5.  Expression and clinical significance of L-plastin in colorectal carcinoma.

Authors:  Jing Li; Ren Zhao
Journal:  J Gastrointest Surg       Date:  2011-09-16       Impact factor: 3.452

6.  miR-375 Regulates Invasion-Related Proteins Vimentin and L-Plastin.

Authors:  Lizandra Jimenez; Jihyeon Lim; Berta Burd; Thomas M Harris; Thomas J Ow; Nicole Kawachi; Thomas J Belbin; Ruth Angeletti; Michael B Prystowsky; Geoffrey Childs; Jeffrey E Segall
Journal:  Am J Pathol       Date:  2017-05-10       Impact factor: 4.307

Review 7.  Molecular chemotherapy for breast cancer.

Authors:  A Patterson; A L Harris
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

8.  Quantitative kinetic study of the actin-bundling protein L-plastin and of its impact on actin turn-over.

Authors:  Ziad Al Tanoury; Elisabeth Schaffner-Reckinger; Aliaksandr Halavatyi; Céline Hoffmann; Michèle Moes; Ermin Hadzic; Marie Catillon; Mikalai Yatskou; Evelyne Friederich
Journal:  PLoS One       Date:  2010-02-15       Impact factor: 3.240

9.  miR-125a-5p regulates megakaryocyte proplatelet formation via the actin-bundling protein L-plastin.

Authors:  Seema Bhatlekar; Bhanu K Manne; Indranil Basak; Leonard C Edelstein; Emilia Tugolukova; Michelle L Stoller; Mark J Cody; Sharon C Morley; Srikanth Nagalla; Andrew S Weyrich; Jesse W Rowley; Ryan M O'Connell; Matthew T Rondina; Robert A Campbell; Paul F Bray
Journal:  Blood       Date:  2020-10-08       Impact factor: 22.113

10.  Transcriptional profiling of ErbB signalling in mammary luminal epithelial cells--interplay of ErbB and IGF1 signalling through IGFBP3 regulation.

Authors:  Jenny Worthington; Mariana Bertani; Hong-Lin Chan; Bertran Gerrits; John F Timms
Journal:  BMC Cancer       Date:  2010-09-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.